ID
11995
Beschreibung
Efficacy of 5 Weeks of Treatment With BGG492 in Patients With Spasticity Due to Multiple Sclerosis; ODM derived from: https://clinicaltrials.gov/show/NCT01649050
Link
https://clinicaltrials.gov/show/NCT01649050
Stichworte
Versionen (1)
- 30.08.15 30.08.15 -
Hochgeladen am
30. August 2015
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Muscle Spasticity Due to Multiple Sclerosis NCT01649050
Eligibility Muscle Spasticity Due to Multiple Sclerosis NCT01649050
- StudyEvent: Eligibility
Beschreibung
Exclusion Criteria
Alias
- UMLS CUI-1
- C0680251
Beschreibung
Patients with symptoms of spasticity not due to MS.
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0026838
Beschreibung
Patients taking three or more different anti-spasticity medications.
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0013227
- UMLS CUI [2]
- C0026838
Beschreibung
Acute MS exacerbation requiring treatment within 3 months of the Screening Visit.
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0235874
- UMLS CUI [2]
- C0026769
Beschreibung
Initiation of, or the discontinuation of interferon beta or any other disease modifying therapy for MS within 3 months of the Screening Visit.
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0015980
Beschreibung
Use of baclofen pump at any time.
Datentyp
boolean
Alias
- UMLS CUI [1]
- C3836732
Beschreibung
Wheelchair or bed-bound patients.
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0043143
Ähnliche Modelle
Eligibility Muscle Spasticity Due to Multiple Sclerosis NCT01649050
- StudyEvent: Eligibility
C0332307 (UMLS CUI [2])
C0026769 (UMLS CUI [2])
C0026769 (UMLS CUI [2])
C0026838 (UMLS CUI [2])
C0026769 (UMLS CUI [2])